
Mecla P 1500mcg/75mg Tablet SR
Marketer
H & Care Incorp
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Mecla P 1500mcg/75mg Tablet SR
Prenoxal SR 1500mcg/75mg tablets are a prescription medication for neuropathic pain management. It alleviates pain by regulating nerve cell calcium channel function. This medication also safeguards nerve fibers and promotes the repair of damaged nerve cells. Prenoxal SR is administered orally, with or without food, ideally before sleep. Consistent daily timing helps maintain stable blood levels. Adhere strictly to your doctor's prescribed dosage and duration, as this medication can be habit-forming. If a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even if symptoms improve. Abrupt cessation should only occur under medical supervision. Common side effects include upper respiratory tract infection, increased hunger, elevated mood, trembling, vision blurring, dry mouth, lightheadedness, and drowsiness. Avoid activities requiring concentration until the medication's effects are known. These side effects are generally mild and improve over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor. Disclose all other medications you're using, as interactions can reduce efficacy or alter the drug's action. Notify your physician if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Mecla P 1500mcg/75mg Tablet SR
There is no text provided to rephrase.
Uses of Mecla P 1500mcg/75mg Tablet SR
Managing neuropathic pain
Major Benefits of Mecla P 1500mcg/75mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Mecla P 1500mcg/75mg Extended-Release Tablet can be ingested with or without food, however, consistent daily timing is recommended.
Common Side effects of Mecla P 1500mcg/75mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Mecla P 1500mcg/75mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. The tablet should be swallowed whole; avoid chewing, crushing, or fracturing it. Mecla P 1500mcg/75mg Sustained-Release Tablet can be ingested with or without food, although consistent timing is recommended.
How Mecla P 1500mcg/75mg Tablet SR works:
Mecla P 1500mcg/75mg SR tablets contain methylcobalamin and pregabalin, working synergistically to manage neuropathic pain. Methylcobalamin, a vitamin B12 derivative, supports myelin sheath formation and repair, protecting nerve fibers. Pregabalin, an alpha-2-delta ligand, reduces pain signals by modifying nerve cell calcium channel function. This combination offers relief from the discomfort associated with nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mecla P 1500mcg/75mg SR tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of Mecla P 1500mcg/75mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Mecla P 1500mcg/75mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Prolonged-release Mecla P 1500mcg/75mg tablets can induce drowsiness, blurred vision, and dizziness. Driving is prohibited should these effects manifest.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Mecla P 1500mcg/75mg sustained-release tablets. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Mecla P 1500mcg/75mg Tablet SR in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Mecla P 1500mcg/75mg Tablet SR :
Should you forget a dose of Mecla P 1500mcg/75mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mecla P 1500mcg/75mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
